![Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abj2177/asset/432f3256-5cb0-4b85-823b-49a35d9163a5/assets/images/large/scitranslmed.abj2177-f4.jpg)
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine
![Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abj2177/asset/8c3fe725-e6eb-42bf-aaa5-24c67c27e4a8/assets/images/large/scitranslmed.abj2177-f3.jpg)
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine
![Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abj2177/asset/0baf1f36-e079-4dda-9073-dd0c732be697/assets/images/large/scitranslmed.abj2177-f1.jpg)